This patent covers non-human cells and stem cells that are "de-immunogenized" so that they may be transplanted into humans without rejection. The patent "de-immunogenizes" the cells by inducing expression of human anticomplement proteins, as well as by suppressing the expression of immunogenic proteins such as those of the MHC type.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.